IRCT201012295500N1已完成3 期
Double-blind randomized comparison of efficacy and side effects of Bupropion versus methyl phenidate in children with Attention Deficit Hyperactivity Disorder (ADHD)
Research vice chancellor of Mashad university of medical sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 years 至 12 years（—）
- 性别
- All
入选标准
- •1-Children 6 to 12 years old with diagnosis of ADHD on the basis of DSM-IV-TR; 2-children without MR (IQ>70); 3-children without medical and neurologic problems specially with a history of epilepsy; 4-children without eating disorders (because of being prone to seizure due to bupropion); 5-agreement of parents in research participation; 6-the child that does not have the history of using Methyl phenidate and Bupropion and other psychiatric drugs. Exclusion criteria: 1-disagreement of parents during the research; 2-existance of severe side effects like neurologic disorders such as convulsion in curing groups.
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
comparison of 2 drugs dexmeditomedine and fentanyl for insertion of supraglottic airway ( i-gel) insertioCTRI/2017/06/008928Department of Anesthesiology60
未知
3 期
Double-blind randomized study to compare the efficacy and safety of tamsulosin prolonged release tablet 0.4 mg with Harnal capsule 0.2 mg in patients with lower urinary tract symptoms (LUTS) associated with benign prostate hyperplasia (BPH)JPRN-jRCT1080221287Astellas Pharma Inc.400
尚未招募
4 期
To see which mode of administration of Injection nalbuphine is more effective in preventing itching caused by painkiller morphineCTRI/2017/04/008332Shri Sathya Sai Medical College and Research Institute90
进行中（未招募）
不适用
Randomized Double-blind Study Comparing the Efficacy of Duloxetine with Placebo in Patients with Chronic Low Back PaiEUCTR2009-012713-22-ATMedizinische Universität Wien, Univ. Klinik für Anästhesie, Allg. Intensivmedizin u Schmerztherapie
已完成
3 期
Randomized double-blind study of efficacy and safety of topical 3% minoxidil solution combined with 0.25% finasteride solution versus 3% minoxidil solution in treatment of male androgenetic alopeciaMale pattern alopeciaMale pattern baldnessAndrogenetic alopeciaTCTR20160910002Division of Dermatology, Ramathibodi Hospital, Mahidol University40